SAMD9 and central nervous system cancer: This is the first report to demonstrate that SAMD9 has a role not only as a significance marker related to malignancy characteristics in glioma, but also may as an independent prognostic indicator in lower grade glioma patients; further study found that SAMD9 influences the immune response by increasing the ability of M2 macrophage to infiltrate in vitro.